Mesoblast Limited

NASDAQ: MESO · Real-Time Price · USD
16.02
-0.23 (-1.42%)
At close: Aug 18, 2025, 1:41 PM

Mesoblast Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-87.96M -81.89M -91.35M -98.81M
Depreciation & Amortization
4.67M 4.11M 4.38M 4.26M
Stock-Based Compensation
5.87M 3.65M 5.54M 12.51M
Other Working Capital
12.84M -2.35M 4.73M -6.68M
Other Non-Cash Items
31.78M 13.54M 11.02M -15.41M
Deferred Income Tax
-191K -212K -235K -819K
Change in Working Capital
-2.63M -2.47M 4.87M -8.42M
Operating Cash Flow
-48.46M -63.27M -65.78M -106.68M
Capital Expenditures
-331K -314K -232K -1.65M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
234K 120K n/a n/a
Other Investing Acitivies
-60K 120K -75K n/a
Investing Cash Flow
-97K -194K -232K -1.65M
Debt Repayment
-13.52M -2.66M -6.33M -2.93M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-11.63M -11.48M -3.75M 5.2M
Financial Cash Flow
40.25M 74.5M -9.87M 114.47M
Net Cash Flow
-8.36M 10.87M -76.43M 7.55M
Free Cash Flow
-48.79M -63.58M -66.01M -108.33M